A PAD2 inhibitor
Technical Support & Resources

Visit our FAQ

Contact Us

Toll Free Phone (USA and Canada Only): (888) 526-5351
Direct Phone: (734) 975-3888

Request Technical Support

Technical Support Request

To streamline the process attach the appropriate questionnaire to your inquiry.

Download IHC QuestionnaireDownload WB Questionnaire

View Our Privacy Statement for details on how we use and protect your data. In addition, this site is protected by hCaptcha and its Privacy Policy and Terms of Service apply.

CAY10723 (hydrochloride)

Item No. 38018

Technical Information
Formal Name
N-[(1S)-4-[(2-fluoro-1-iminoethyl)amino]-1-(4-methoxy-1-methyl-1H-benzimidazol-2-yl)butyl]-2,3-dihydro-3-oxo-1H-isoindole-4-carboxamide, monohydrochloride
Synonyms
  • AFM30a
  • AMF30a
Molecular Formula
C24H27FN6O3 • HCl
Formula Weight
Purity
≥95%
Formulation
A solid
DMF: 30 mg/mlDMSO: 30 mg/mlEthanol: 5 mg/mlPBS (pH 7.2): 10 mg/ml
SMILES
O=C(N[C@@H](CCCNC(CF)=N)C1=NC2=C(C=CC=C2OC)N1C)C3=C(C(NC4)=O)C4=CC=C3.Cl
InChi Code
InChI=1S/C24H27FN6O3.ClH/c1-31-17-9-4-10-18(34-2)21(17)30-22(31)16(8-5-11-27-19(26)12-25)29-23(32)15-7-3-6-14-13-28-24(33)20(14)15;/h3-4,6-7,9-10,16H,5,8,11-13H2,1-2H3,(H2,26,27)(H,28,33)(H,29,32);1H/t16-;/m0./s1
InChi Key
HDGZNBCVLSJSHI-NTISSMGPSA-N
Shipping & Storage Information
Storage
-20°C
Shipping
Room temperature in continental US; may vary elsewhere
Recommended Products

Certificates of Analysis & Batch Specific Data

Provide batch numbers separated by commas to download or request available product inserts, QC sheets, certificates of analysis, data packs, and GC-MS data.

    Add

    Add

    Add

    Cayman Chemical
    Neutrophil Biology Wall Poster

    Explore how neutrophils shape the immune response in health and disease. This poster highlights neutrophil pathogen defense mechanisms, including phagocytosis, degranulation, and NETosis, as well as neutrophil roles in inflammation and NET-associated pathologies.

    DOWNLOAD NOW
    Product Description

    CAY10723 is an inhibitor of peptidyl arginine deiminase 2 (PAD2; EC50 = 9.5 μM in a cellular target engagement assay).1 It is approximately 1.6-, 47-, and 15-fold selective for PAD2 over PAD1, PAD3, and PAD4, respectively. CAY10723 inhibits histone H3 citrullination in HEK293T cells expressing human PAD2 (EC50 = 0.4 μM). It also inhibits fibrinogen citrullination in the presence of isolated human polymorphonuclear leukocytes (PMNs) or synovial fluid from patients with rheumatoid arthritis when used at a concentration of 20 µM.2 CAY10723 (25 µM) decreases IFN-γ production in isolated human CD4+ T cells.3

    WARNING This product is not for human or veterinary use.

    References & Product Citations
    Product Description References

    1. Muth, A., Subramanian, V., Beaumont, E., et alDevelopment of a selective inhibitor of protein arginine deiminase 2. J. Med. Chem. 60(7), 3198-3211 (2017).

    2. Monreal, M.T.M., Rebak, A.S., Massarenti, L., et alApplicability of small-molecule inhibitors in the study of peptidyl arginine deiminase 2 (PAD2) and PAD4. Front. Immunol. 12, 716250 (2021).

    3. Liu, Y., Lightfood, Y.L., Seto, N., et alPeptidylarginine deiminases 2 and 4 modulate innate and adaptive immune responses in TLR-7-dependent lupus. JCI Insight 3(23), e124729 (2018).

    Product Citations

    Jin, F., Li, Y., Li, T., et alInhibition of PADI2-mediated vimentin citrullination alleviates silica-induced pulmonary fibrosis in mice. Part. Fibre. Toxicol. (2026).

    Pasquero, S., Gugliesi, F., Griffante, G., et alNovel antiviral activity of PAD inhibitors against human beta-coronaviruses HCoV-OC43 and SARS-CoV-2. Antiviral Res. 200, 105278 (2022).